antiplatelet
英
美
网络 抗血小板; 抗血小板药物; 抗血小板药; 血小板
双语例句
- Antiplatelet therapy does not slow the progression of coronary artery disease ( CAD) in the first year following ST-segment elevation myocardial infarction ( STEMI), study findings indicate.
研究结果表明，抗血小板治疗未能延缓ST段抬高型心肌梗死（STEMI）后一年的冠心病（CAD）进展。 - Reduced antiplatelet drug responsiveness, including resistance to currently used oral antiplatelet agents, has been suggested to play a role in these worse outcomes.
降低抗血小板药物反应性已被认为在这些更糟的结果的出现中起到了推波助澜的作用，其中就包括对目前常用口服抗血小板剂的抵制。 - In my opinion, it is not with triple therapy that we can solve this problem but with alternative antiplatelet agents.
我觉得，三重治疗并不能解决问题，而应该选择其他可选择的抗血小板药物。 - And there's consensus that the increased ischemic events are related to insufficient antiplatelet and antithrombotic therapy.
现在专家的一致意见认为，这可能是由于抗血小板和抗血栓治疗不足所引起的。 - The search for a useful clinical laboratory diagnostic assay for the antiplatelet antibodies has been long and difficult.
探索有效的检测血小板抗体的临床实验方法经历了漫长和艰辛的过程。 - Objective Observation and analysis of separate United anticoagulation and antiplatelet therapy in the treatment of cardiac cerebral infarction clinical significance.
目的：观察分析单独抗血小板治疗与联合抗凝治疗在心源性脑梗塞中的临床意义。 - Other nonselective over-the-counter nonsteroidal anti-inflammatory drugs should be viewed as having the potential to interfere with the antiplatelet effect of low-dose aspirin unless proven otherwise.
其他非选择性的非处方非激素类抗炎药物应考虑对低剂量阿司匹林抗凝血功能有潜在的干扰，除非用别的方法证明。 - But these antiplatelet drugs also increase the risk of bleeding, including upper GI bleeding.
但是这些抗血小板药物也增加出血的风险，包括上消化道出血。 - Antiplatelet Therapy for Secondary Prevention of Cardiovascular Events: More "Advanced" Drug, More Perfect?
心血管事件的二级预防：抗血小板治疗药物越“先进”越完美吗？ - Novel and more potent antiplatelet agents currently under clinical development will be useful in efforts to reach these therapeutic goals.
随着临床的发展，当前新型的以及更为有效的抗血小板剂将有助于达到这些治疗的效果。 - There are new anticoagulants with some peculiar features that represent an improvement even though they are still in an early phase of development and also new antiplatelet agents.
尽管仍处于研究早期阶段，但确实有一些新的具有独特特征的确代表新发展的抗凝药，和抗血小板药物。 - Objective: To investigate the safety and efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention.
目的：探讨糖尿病合并冠心病老年患者支架植入术后三联抗血小板治疗对预防支架内血栓形成和再狭窄的有效性及安全性。 - The risk of major bleeding complications is not increased with the combination, which suggests that dipyridamole might act in another way than as antiplatelet drug.
联合用药不增加出血性并发症的风险，因此表明双嘧达莫可能有除作为抗血小板药物外的另一种作用。 - A rapid and sensitive method for monitoring platelet ATP release function and its application in antiplatelet studies
一种快速、灵敏的血小板释放功能检测方法及其在抗血小板药物研究中的应用 - Anticoagulation use has increased in nontargeted, low-risk groups in whom antiplatelet agents are appropriate.
在那些接受抗血小板治疗更加合适的低危险组病人中，抗凝治疗的使用也呈增加趋势。 - Anticoagulative Effect and Antiplatelet Aggregation Effect of Combination of Hirudo and Tabanus on Rat Model of Blood Stasis Syndrome
水蛭、虻虫配伍的抗凝血和抗血小板聚集的作用 - This article introduces the mechanism of currently available antiplatelet drugs as well as their practice guidelines and evidence from clinical trials.
本文介绍了常用抗血小板药物的作用机制以及指南性建议和临床试验证据。 - The FDA also recommends prolonged dual antiplatelet therapy for at least a year following the intervention.
FDA也推荐介入治疗后至少延长一年对病人进行双重抗血小板治疗。 - Additional infusion of IVIG and steroid treatment with antiplatelet and anticoagulant medications have good effects on IVIG resistant Kawasaki disease.
复用IVIG及必要时在抗凝基础上加用激素对IVIG不敏感川崎病治疗有较好疗效。 - The Influence of Atorvastatin or Rosuvastatin on Antiplatelet Function of Clopidogrel The Research of Co-administration Between the Statins and Clopidogrel
瑞舒伐他汀和阿托伐他汀对氯吡格雷抗血小板活性的影响氯吡格雷与他汀类药物的相互作用研究进展 - We speculate that in the later cohort clinicians were more aware of the risk of DES and prolonged antiplatelet therapy.
我们推测，在后来的队列研究中，临床医师更加重视DES的风险，并延长了抗血小板治疗时间。 - For patients with cryptogenic stroke associated with mobile aortic arch thrombi, we suggest either oral anticoagulation or antiplatelet agents ( Grade2C).
对于伴有主动脉弓活动性血栓的不明原因卒中患者，建议或者口服抗凝，或者服用抗血小板药物（2C级）。 - Using antiplatelet drugs in the treatment of long-term indwelling catheters developing into late dysfunction
抗血小板药在治疗长期留置血液透析导管晚期功能不良中的应用 - Antiplatelet therapy for ischemic cerebrovascular diseases
抗血小板药物治疗缺血性脑血管病的合理应用 - ACTIVE A now adds to our understanding of the role of intensive antiplatelet therapy to prevent stroke in selected patients with atrial fibrillation.
现在ACTIVEA结果加入到我们对于强效抗血小板治疗在选择性预防房颤病人卒中作用的理解中。 - These findings underscore the need of individualized antiplatelet treatment regimens in diabetic patients.
这些结果都强调了对于糖尿病患者抗血小板治疗方案的个体化需要。 - The status of antiplatelet therapy at the time of ST was known for most patients.
已知大多数患者ST发生时抗血小板治疗的情况。 - With occasional use of ibuprofen, there is likely to be minimal risk from any attenuation of the antiplatelet effect of low-dose aspirin, because of the long-lasting effect of aspirin on platelets.
偶尔使用布洛芬，对降低低剂量的阿司匹林抗凝血功能的风险可能性最小，因为阿斯匹林对血小板具有长而持久的影响。 - The exact mechanism remains unclear, however, because EPA has antihyperlipidemic, antiplatelet, anti-inflammatory and antiarrhythmic effects.
确切的保护机制仍不清楚，然而，因为EPA有着抗高血脂、抗血小板、抗炎和抗心律不齐的作用。 - The report makes a number of practical recommendations to eliminate early discontinuation of antiplatelet therapy.
这个报道列出了多条实用的建议来减少早期停用抗血小板治疗。